201 KAR 2:220. Collaborative care
agreements.
RELATES TO: KRS 315.010(4), 315.040(4),
315.191(1)(a)
STATUTORY AUTHORITY: KRS 315.191(1)(a)
NECESSITY, FUNCTION, AND CONFORMITY: KRS
315.191(1)(a) authorizes the Board of Pharmacy to promulgate administrative
regulations to regulate and control matters relating to pharmacists, pharmacist
interns, pharmacist technicians, pharmacies, wholesale distributors, and
manufacturers. This administrative regulation establishes minimum requirements
for the development and maintenance of collaborative care agreements between an
individual pharmacist and an individual practitioner.
Section 1. A collaborative care agreement
shall:
(1) Be in writing;
(2) Be signed and dated by the:
(a) Individual practitioner;
(b) Individual pharmacist; and
(c) Patient or care giver;
(3) Provide that upon termination of the
agreement the individual practitioner or individual pharmacist shall notify the
patient in writing;
(4) State the method for termination of
the agreement; and
(5) Contain the information specified by
Section 2 of this administrative regulation.
Section 2. A collaborative care agreement
shall contain the following information:
(1) Patient name;
(2) Patient address and telephone number;
(3) Protocol, criteria, standing orders,
or other method by which services are authorized;
(4) The method established for the
assessment of patient outcomes, if appropriate; and
(5) Lab tests that may be ordered.
Section 3. The following information
relating to a collaborative care agreement shall be maintained by a pharmacist
and shall be provided to the collaborating practitioner:
(1) Emergency notification contact;
(2) Date of birth, weight, height, and
gender;
(3) Prescription regimen;
(4) Nonprescription regimen;
(5) Medical history; including:
(a) Known diseases;
(b) Known allergies; and
(c) Reactions and conditions relating to:
1. Prescription regimens; and
2. Nonprescription regimens;
(6) Lab tests ordered, including results
of lab tests;
(7) Assessments of patient outcomes;
(8) Notes relating to contacts between
the individual pharmacist and the individual practitioner concerning the care
and course of therapy of the patient; and
(9) Documentation of the specific
counseling information provided to the patient or care giver.
Section 4. A collaborative care
agreement, and information and records required by the provisions of this
administrative regulation, shall be maintained:
(1) At the pharmacist's practice site;
and
(2) For at least five (5) years after
termination. (23
Ky.R. 3125; Am. 3807; 4109; eff. 6-16-97; 34 Ky.R. 2421; eff. 8-1-2008.)